1,607 Shares in The Goldman Sachs Group, Inc. $GS Purchased by Sun Financial Inc

Sun Financial Inc bought a new position in The Goldman Sachs Group, Inc. (NYSE:GS) during the 4th quarter, HoldingsChannel reports. The fund bought 1,607 shares of the investment management company’s stock, valued at approximately $1,412,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Acropolis Investment Management LLC lifted its stake in shares of The Goldman Sachs Group by 1.8% in the fourth quarter. Acropolis Investment Management LLC now owns 630 shares of the investment management company’s stock worth $554,000 after buying an additional 11 shares in the last quarter. Walkner Condon Financial Advisors LLC lifted its stake in shares of The Goldman Sachs Group by 2.0% in the fourth quarter. Walkner Condon Financial Advisors LLC now owns 574 shares of the investment management company’s stock worth $505,000 after buying an additional 11 shares in the last quarter. Optas LLC lifted its stake in shares of The Goldman Sachs Group by 0.4% in the fourth quarter. Optas LLC now owns 2,553 shares of the investment management company’s stock worth $2,244,000 after buying an additional 11 shares in the last quarter. Pines Wealth Management LLC lifted its stake in shares of The Goldman Sachs Group by 0.4% in the fourth quarter. Pines Wealth Management LLC now owns 2,566 shares of the investment management company’s stock worth $2,255,000 after buying an additional 11 shares in the last quarter. Finally, Terra Nova Asset Management LLC lifted its stake in shares of The Goldman Sachs Group by 0.5% in the fourth quarter. Terra Nova Asset Management LLC now owns 2,650 shares of the investment management company’s stock worth $2,329,000 after buying an additional 12 shares in the last quarter. Institutional investors own 71.21% of the company’s stock.

The Goldman Sachs Group Stock Down 0.0%

GS opened at $923.32 on Monday. The company has a quick ratio of 0.66, a current ratio of 1.10 and a debt-to-equity ratio of 2.56. The firm has a 50 day moving average price of $869.26 and a 200-day moving average price of $867.57. The Goldman Sachs Group, Inc. has a twelve month low of $547.06 and a twelve month high of $984.70. The stock has a market capitalization of $272.37 billion, a price-to-earnings ratio of 16.87, a PEG ratio of 1.19 and a beta of 1.28.

The Goldman Sachs Group (NYSE:GS) last announced its earnings results on Monday, April 13th. The investment management company reported $17.55 EPS for the quarter, beating analysts’ consensus estimates of $15.92 by $1.63. The Goldman Sachs Group had a net margin of 14.13% and a return on equity of 16.02%. The business had revenue of $17.23 billion during the quarter, compared to analysts’ expectations of $16.66 billion. During the same period in the prior year, the company earned $14.12 earnings per share. The firm’s revenue was up 14.4% on a year-over-year basis. Equities research analysts forecast that The Goldman Sachs Group, Inc. will post 59.53 earnings per share for the current year.

The Goldman Sachs Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 29th. Shareholders of record on Monday, June 1st will be issued a dividend of $4.50 per share. This represents a $18.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Monday, June 1st. The Goldman Sachs Group’s dividend payout ratio is currently 32.89%.

Trending Headlines about The Goldman Sachs Group

Here are the key news stories impacting The Goldman Sachs Group this week:

• Positive Sentiment: Shareholders backed Goldman’s board and rejected proposed governance changes, removing near-term proxy uncertainty and supporting management continuity. Goldman Sachs Shareholders Back Board, Reject Governance Changes
• Positive Sentiment: Goldman is a lead bookrunner on Hemab Therapeutics’ IPO ($~301.5M), a visible ECM win that should produce fees and signal continued dealflow for Goldman’s equities and ECM franchise. Hemab Therapeutics Announces Pricing of Initial Public Offering at $18.00 Per Share
• Positive Sentiment: Goldman has been tapped to lead a potential IPO for Italy’s Dolomiti Energia and ranked #1 by value on oil & gas M&A in Q1 — both items point to continued IB fee opportunities. Italy’s Dolomiti Energia picks Intesa, Goldman Sachs to lead potential IPO Goldman Sachs tops oil and gas M&A rankings by value in Q1 2026
• Neutral Sentiment: Goldman research added UnitedHealth (UNH) to its Conviction List — bolsters the firm’s research credibility and may support institutional relationships, but is indirect for GS’s own stock. Goldman Sachs Adds UnitedHealth to Its Conviction List: Is the Managed Care Comeback Real?
• Neutral Sentiment: Goldman raised its oil price outlook and its analysts are reiterating thematic calls (favoring tech giants for AI exposure). These research moves highlight Goldman’s market influence but have a more indirect impact on GS revenue. Goldman Sachs Just Raised Its Oil Price Forecast. Here’s What Energy Investors Should Do Now. Why Goldman Sachs Prefers Tech Giants Over Semiconductor Stocks for AI Exposure
• Neutral Sentiment: Goldman analysts flagged unusually thin S&P 500 breadth (dot?com era levels), a market?risk signal that influences client flows and positioning but is a macro research call rather than firm-specific news. S&P 500 Hasn’t Looked This Unbalanced Since The Dot-Com Bubble, Goldman Warns
• Negative Sentiment: Jane Street reported massive trading revenues and sharply higher compensation — a sign of fierce competition and elevated market?making payouts that could pressure Goldman’s trading margins and require higher pay to retain talent. Jane Street Pays $9.38 Billion As Trading Revenue Hits $39.6 Billion
• Negative Sentiment: Breakingviews commentary warns Goldman is dialing up private?credit exposure, highlighting a higher risk/return tradeoff in a market that could widen losses if conditions deteriorate. That strategy can boost fee income but raises balance?sheet and credit risk. Goldman Sachs dials up private credit risk-reward

Insider Buying and Selling at The Goldman Sachs Group

In other The Goldman Sachs Group news, EVP John F.W. Rogers sold 2,704 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $960.99, for a total transaction of $2,598,516.96. Following the completion of the sale, the executive vice president directly owned 9,428 shares of the company’s stock, valued at approximately $9,060,213.72. This represents a 22.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Alex S. Golten sold 1,116 shares of the company’s stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $936.18, for a total transaction of $1,044,776.88. Following the sale, the insider directly owned 2,578 shares of the company’s stock, valued at approximately $2,413,472.04. This represents a 30.21% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 32,001 shares of company stock valued at $30,367,306. Insiders own 0.55% of the company’s stock.

Wall Street Analysts Forecast Growth

GS has been the topic of several analyst reports. Weiss Ratings upgraded shares of The Goldman Sachs Group from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, April 24th. UBS Group reiterated a “neutral” rating and issued a $930.00 target price on shares of The Goldman Sachs Group in a research note on Monday, April 13th. Argus upped their target price on shares of The Goldman Sachs Group from $863.00 to $1,066.00 and gave the stock a “buy” rating in a research note on Friday, January 16th. BNP Paribas Exane decreased their price objective on shares of The Goldman Sachs Group from $970.00 to $940.00 and set a “neutral” rating for the company in a report on Friday, April 24th. Finally, Jefferies Financial Group decreased their price objective on shares of The Goldman Sachs Group from $1,125.00 to $1,049.00 and set a “buy” rating for the company in a report on Monday, April 6th. Nine analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. According to data from MarketBeat.com, The Goldman Sachs Group currently has an average rating of “Hold” and a consensus price target of $922.71.

The Goldman Sachs Group Profile

The Goldman Sachs Group, Inc is a global investment banking and financial services firm headquartered in New York City. Founded in 1869 as a commercial paper business, the company has grown into a diversified financial institution that provides a broad range of services to corporations, financial institutions, governments and individuals. The firm is led by Chief Executive Officer David M. Solomon and operates across major financial centers worldwide.

Goldman Sachs’ core businesses include investment banking, global markets, asset and wealth management, and consumer banking.